Published in PLoS One on May 17, 2013
Global genomic diversity of human papillomavirus 6 based on 724 isolates and 190 complete genome sequences. J Virol (2014) 0.83
Human papillomavirus infection in oral fluids of HIV-1-positive men: prevalence and risk factors. Sci Rep (2014) 0.81
Global Genomic Diversity of Human Papillomavirus 11 Based on 433 Isolates and 78 Complete Genome Sequences. J Virol (2016) 0.77
Differences in Transcriptional Activity of Human Papillomavirus Type 6 Molecular Variants in Recurrent Respiratory Papillomatosis. PLoS One (2015) 0.75
Correction: human papillomavirus type 6 and 11 genetic variants found in 71 oral and anogenital epithelial samples from australia. PLoS One (2015) 0.75
MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol (2011) 220.97
Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol (2000) 128.08
A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol (1980) 113.75
SeaView version 4: A multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol Biol Evol (2009) 21.24
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology (2010) 7.24
Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol (2012) 6.05
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer (2011) 5.43
Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis (2010) 5.39
The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci U S A (1991) 5.31
The Rb/E2F pathway and cancer. Hum Mol Genet (2001) 4.98
HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med (2011) 4.69
Natural history of genital warts. Br J Vener Dis (1971) 4.22
Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet (2011) 3.86
Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer (2004) 3.40
Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis (2009) 2.92
Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer (2009) 2.90
Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis (2005) 2.51
Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women. Sex Transm Infect (2009) 2.30
Recurrent respiratory papillomatosis: a review. Laryngoscope (2008) 2.11
A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev (2008) 2.10
Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests. J Clin Microbiol (2006) 1.78
Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review. BMC Cancer (2012) 1.66
The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect (2011) 1.61
Current concepts on human papillomavirus infections in children. APMIS (2010) 1.57
Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma. Oncogene (2005) 1.50
Appraisal of the burden of genital warts from a healthcare and individual patient perspective. Public Health (2011) 1.49
Transcription of episomal papillomavirus DNA in human condylomata acuminata and Buschke-Löwenstein tumours. J Gen Virol (1984) 1.49
Clearance of human papillomavirus in women treated for cervical dysplasia. Obstet Gynecol (2011) 1.45
Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53. Laryngoscope (1998) 1.29
Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol (1995) 1.25
The psychosocial burden of human papillomavirus related disease and screening interventions. Sex Transm Infect (2009) 1.24
Trends in anal cancer in Australia, 1982-2005. Vaccine (2011) 1.24
Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia. Sex Health (2011) 1.22
Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope (2004) 1.19
Human papillomavirus genotyping using archival vulval dysplastic or neoplastic biopsy tissues: comparison between the INNO-LiPA and linear array assays. J Clin Microbiol (2010) 1.18
HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia. J Med Virol (2009) 1.18
Classification and nomenclature system for human Alphapapillomavirus variants: general features, nucleotide landmarks and assignment of HPV6 and HPV11 isolates to variant lineages. Acta Dermatovenerol Alp Pannonica Adriat (2011) 1.14
Tobacco smoking as a risk factor in anal carcinoma: an antiestrogenic mechanism? J Natl Cancer Inst (1999) 1.13
Prevalence, genotype diversity and determinants of anal HPV infection in HIV-uninfected men having sex with men. J Clin Virol (2012) 1.12
Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne, Australia. Int J Gynecol Cancer (2006) 1.04
Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer. Laryngoscope (2004) 1.00
Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr Dev Pathol (2001) 0.98
Screening for anal cancer: endpoints needed. Lancet Oncol (2012) 0.95
Juvenile laryngeal papillomatosis in a pediatric population: a clinicopathologic study. Pediatr Pathol Lab Med (1997) 0.95
Detection of HPV types and neutralizing antibodies in Gansu province, China. J Med Virol (2009) 0.94
What can surveillance of genital warts tell us? Sex Health (2010) 0.91
Comparison of the INNO-LiPA and PapType assays for detection of human papillomavirus in archival vulva dysplasia and/or neoplasia tissue biopsy specimens. J Clin Microbiol (2011) 0.91
The frequency of high-grade intraepithelial neoplasia in anal/perianal warts is higher than previously recognized. Int J STD AIDS (2007) 0.89
Prevalence of human papillomavirus types 6, 11, 16, 18, 31, and 33 in a cohort of Greek women. J Med Virol (2007) 0.89
Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis. J Clin Microbiol (1997) 0.87
Identical human papillomavirus (HPV) genomic variants persist in recurrent respiratory papillomatosis for up to 22 years. J Infect Dis (2012) 0.87
Prevaccination genomic diversity of human papillomavirus genotype 6 (HPV 6). Virology (2009) 0.85
Intrabody strategies for the treatment of human papillomavirus-associated disease. Expert Opin Biol Ther (2007) 0.85
Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens. J Med Virol (2012) 0.84
Prevalence of human papillomavirus among women with normal cervical cytology in Kuwait. J Med Virol (2011) 0.83
Prevaccination genomic diversity of human papillomavirus genotype 11: a study on 63 clinical isolates and 10 full-length genome sequences. J Med Virol (2011) 0.83
Pre-vaccination genomic diversity of human papillomavirus genotype 6 (HPV 6): a comparative analysis of 21 full-length genome sequences. Infect Genet Evol (2011) 0.82
Virological failure of intralesional cidofovir therapy in recurrent respiratory papillomatosis is not associated with genetic or epigenetic changes of HPV11: complete genome comparison of sequential isolates. Antiviral Res (2011) 0.82
Novel HPV-6 variants of human papillomavirus causing recurrent respiratory papillomatosis in southern Africa. Epidemiol Infect (2011) 0.81
Human papillomavirus type 6: classification of clinical isolates and functional analysis of E2 proteins. J Gen Virol (1999) 0.80
Distribution of HPV genotypes in Slovenian patients with anal carcinoma: preliminary results. Acta Dermatovenerol Alp Pannonica Adriat (2011) 0.79
Whole genome analysis of human papillomavirus genotype 11 from cervix, larynx and lung. Asian Pac J Cancer Prev (2012) 0.79
Lack of methylation in the upstream region of human papillomavirus type 6 from aerodigestive tract papillomas. J Virol (2012) 0.79
Sequence variation in the early genes E1E4, E6 and E7 of human papilloma virus type 6. Virus Res (1997) 0.77
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol (2010) 9.86
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med (2015) 7.99
Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol (2012) 6.05
High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis (2006) 5.96
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol (2011) 5.57
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. J Infect Dis (2009) 5.09
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst (2010) 4.20
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol (2011) 3.98
Web-based recruiting for health research using a social networking site: an exploratory study. J Med Internet Res (2012) 3.82
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. J Infect Dis (2009) 3.55
Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis (2008) 3.05
A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine (2012) 3.03
Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J Infect Dis (2005) 3.00
Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis (2012) 2.51
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res (Phila) (2009) 2.42
Early acquisition of anogenital human papillomavirus among teenage men who have sex with men. J Infect Dis (2013) 2.40
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. Vaccine (2008) 2.09
Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis (2006) 1.98
Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia. Sex Transm Infect (2011) 1.78
Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests. J Clin Microbiol (2006) 1.78
Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance. Cancer Epidemiol Biomarkers Prev (2011) 1.74
Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use. Clin Infect Dis (2012) 1.74
Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial. Gynecol Oncol (2012) 1.70
Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection. Hum Vaccin (2009) 1.66
Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results. J Clin Microbiol (2007) 1.66
Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men. J Infect Dis (2011) 1.64
Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets. Vaccine (2010) 1.57
Evaluation of self-collected samples in contrast to practitioner-collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas. Sex Transm Dis (2002) 1.54
Clearance of human papillomavirus in women treated for cervical dysplasia. Obstet Gynecol (2011) 1.45
An audit of obstetricians' management of women potentially infected with blood-borne viruses. Med J Aust (2004) 1.42
Evaluation of opa-based real-time PCR for detection of Neisseria gonorrhoeae. Sex Transm Dis (2005) 1.39
The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassay. Hum Vaccin (2011) 1.35
Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women. Cancer Epidemiol Biomarkers Prev (2010) 1.34
Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis. Obstet Gynecol (2005) 1.31
Measurement of interleukin 8 in combination with C-reactive protein reduced unnecessary antibiotic therapy in newborn infants: a multicenter, randomized, controlled trial. Pediatrics (2004) 1.31
The epidemiology of anal cancer. Sex Health (2012) 1.30
Oral human papillomavirus in men having sex with men: risk-factors and sampling. PLoS One (2012) 1.28
Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis. PLoS One (2012) 1.27
Development and evaluation of an ompA quantitative real-time PCR assay for Chlamydia trachomatis serovar determination. J Clin Microbiol (2010) 1.24
Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program. BMC Med (2011) 1.23
Chlamydia trachomatis incidence and re-infection among young women--behavioural and microbiological characteristics. PLoS One (2012) 1.21
Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler 480 system. J Virol Methods (2007) 1.19
Characterization of Chlamydia trachomatis omp1 genotypes detected in eye swab samples from remote Australian communities. J Clin Microbiol (2004) 1.18
Human papillomavirus genotyping using archival vulval dysplastic or neoplastic biopsy tissues: comparison between the INNO-LiPA and linear array assays. J Clin Microbiol (2010) 1.18
A chlamydia prevalence survey of young women living in Melbourne, Victoria. Sex Health (2006) 1.18
HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia. J Med Virol (2009) 1.18
Variability of the Chlamydia trachomatis omp1 gene detected in samples from men tested in male-only saunas in Melbourne, Australia. J Clin Microbiol (2004) 1.17
Bacterial vaginosis (BV) candidate bacteria: associations with BV and behavioural practices in sexually-experienced and inexperienced women. PLoS One (2012) 1.16
Evaluation of a modified reverse line blot assay for detection and typing of human papillomavirus. Am J Clin Pathol (2005) 1.15
Early experience with human papillomavirus vaccine introduction in the United States, Canada and Australia. Vaccine (2008) 1.15
Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection. Int J Cancer (2011) 1.12
Human papillomavirus genotyping using a modified linear array detection protocol. J Virol Methods (2006) 1.11
Participants' perspectives of high resolution anoscopy. Sex Health (2011) 1.08
Participants' perspectives of self-collected anal cytological swabs. Sex Health (2011) 1.06
'The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women'. BMC Infect Dis (2011) 1.05
Anal and perianal squamous carcinomas and high-grade intraepithelial lesions exclusively associated with "low-risk" HPV genotypes 6 and 11. Int J Cancer (2013) 1.05
Prevalence of sexually transmitted infections among antenatal women in Vanuatu, 1999-2000. Sex Transm Dis (2003) 1.05
Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study. PLoS One (2013) 1.04
Antibiotic susceptibility of coagulase-negative staphylococci isolated from very low birth weight babies: comprehensive comparisons of bacteria at different stages of biofilm formation. Ann Clin Microbiol Antimicrob (2010) 1.01
A case-control study of mastitis: nasal carriage of Staphylococcus aureus. BMC Fam Pract (2006) 1.01
Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics (2013) 1.01
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation. J Infect Dis (2013) 1.00
Attitudes to Chlamydia screening elicited using the social networking site Facebook for subject recruitment. Sex Health (2013) 1.00
Chlamydia trachomatis genotypes among men who have sex with men in Australia. Sex Transm Dis (2011) 1.00
Exploring 'best practice' for nucleic acid detection of Neisseria gonorrhoeae. Sex Health (2008) 1.00
The aetiological role of human papillomavirus in oesophageal squamous cell carcinoma: a meta-analysis. PLoS One (2013) 1.00
Does HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillance. Future Microbiol (2012) 0.99
Prevalent and incident bacterial vaginosis are associated with sexual and contraceptive behaviours in young Australian women. PLoS One (2013) 0.97
Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. Vaccine (2013) 0.96